Fludarabine, busulfan, and thiotepa may be a promising conditioning regimen for myelofibrosis patients undergoing allogeneic stem cell transplantation

被引：0
|
作者：
Shouval, Roni [1 ]
Vega, Yakov [1 ]
Fein, Joshua A. [1 ]
Danylesko, Ivetta [1 ]
Tov, Noga Shem [1 ]
Yerushalmi, Ronit [1 ]
Nagler, Arnon [1 ]
Shimoni, Avichai [1 ]
机构：
[1] Tel Aviv Univ, Chaim Sheba Med Ctr, Hematol & Bone Marrow Transplantat, Ramat Gan, Israel
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P096
引用
收藏
页码：204 / 205
页数：2
相关论文
共 50 条
  • [21] Regimen related toxicity after thiotepa, cyclophosphamide and intravenous busulfan as conditioning for allogeneic stem cell transplantation
    Sanz, J
    Sanz, GF
    Moscardó, F
    Cupelli, L
    Montesinos, P
    Puig, N
    Lorenzo, I
    Benlloch, L
    Jarque, I
    de la Rubia, J
    Martínez, J
    Martín, G
    Sanz, MA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 33 - 34
  • [22] Intravenous busulfan in combination with thiotepa and fludarabine (TBF) as preparative regimen for patients with lymphoma submitted to allogeneic stem cell transplantation (HCT)
    Pennese, E.
    Santarone, S.
    Olioso, P.
    Bavaro, P.
    Papalinetti, G.
    Accorsi, P.
    Bonhni, T.
    Papola, F.
    Di Bartolomeo, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S132 - S133
  • [23] FLUDARABINE AND TREOSULPHAN IS AN EFFECTIVE CONDITIONING REGIMEN FOR ADULT PATIENTS WITH MDS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
    Ljungman, P.
    LeBlanc, K.
    Engstrom, M.
    Jadersten, M.
    Reykdal, S.
    Mattsson, J.
    Remberger, M.
    Hellstrom-Lindberg, E.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S187 - S188
  • [24] COMPARISON OF IV BUSULFAN AND FLUDARABINE VS IV BUSULFAN AND CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN IN MYELOABALTIVE ALLOGENEIC STEM CELL TRANSPLANTATION
    de Villambrosia, S. Gonzalez
    Moreto, A.
    Nunez, J.
    Bermudez, A.
    Yanez, L.
    Insunza, A.
    Iriondo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 142 - 142
  • [25] A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia
    Yabe, Miharu
    Sako, Masahiro
    Yabe, Hiromasa
    Osugi, Yuko
    Kurosawa, Hidemitsu
    Nara, Taemi
    Tokuyama, Mika
    Adachi, Souichi
    Kobayashi, Chie
    Yanagimachi, Masakatsu
    Ohtsuka, Yoshitoshi
    Nakazawa, Yozo
    Ogawa, Chitose
    Manabe, Atsushi
    Kojima, Seiji
    Nakahata, Tatsutoshi
    PEDIATRIC TRANSPLANTATION, 2008, 12 (08) : 862 - 867
  • [26] Treosulfan in combination with fludarabine as conditioning for allogeneic stem cell transplantation in myelofibrosis
    Kragl, B.
    Heinz, F.
    Grosse-Thie, C.
    Henze, L.
    Lakner, J.
    Freitag, S.
    Wittke, C.
    Brueckner, F.
    Junghanss, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 151 - 152
  • [27] Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation
    Dulery, Remy
    Bastos, Juliana
    Paviglianiti, Annalisa
    Malard, Florent
    Brissot, Eolia
    Battipaglia, Giorgia
    Mediavilla, Clemence
    Giannotti, Federica
    Banet, Anne
    Van de Wyngaert, Zoe
    Ledraa, Tounes
    Belhocine, Ramdane
    Sestili, Simona
    Adaeva, Rosa
    Lapusan, Simona
    Isnard, Francoise
    Legrand, Ollivier
    Vekhoff, Anne
    Rubio, Marie-Therese
    Ruggeri, Annalisa
    Mohty, Mohamad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) : 1407 - 1415
  • [28] Thiotepa-based conditioning regimens in allogeneic hematopoietic stem cell transplantation for patients with myelofibrosis
    Dulery, R.
    Giannotti, F.
    Battipaglia, G.
    Ruggeri, A.
    Brissot, E.
    Malard, F.
    Sestili, S.
    Belhocine, R.
    Vekhoff, A.
    Gueye, M. S.
    Lapusan, S.
    Adaeva, R.
    Isnard, F.
    Legrand, O.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S337 - S337
  • [29] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Sohn, S. K.
    Chae, Y. S.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J. J.
    Kim, Y. K.
    Kim, H. J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S203 - S204
  • [30] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Chae, Y. S.
    Sohn, S. K.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J-J
    Kim, Y-K
    Kim, H-J
    BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 541 - 547
12345